Secondary outcomes were the mean changes in anthropometric parameters, such as body weight, BMI, and waist circumference, glucose control (FPG, HbA1c, insulin resistance), and validated clinical scores predicting the risk of NAFLD (HSI, FLI, APRI, and FIB4) over the entire observation period (T0, T3, and T6)
Despite these benefits, long-term LC administration has been associated to cardiovascular risks due its conversion to trimethylamine- N -oxide (TMAO) by the gut microbiota
For those researching peptide options, comprehensive safety data provides the foundation for informed decision-making
Written by Mace Scott, MD Founder and Medical Director at Chronos Body Health & Wellness Focus: medical weight loss, hormone optimization, wellness medicine, aesthetics Updated: June 2026 Educational Disclaimer: This article is intended for educational and informational purposes only and should not be considered medical advice